263 related articles for article (PubMed ID: 30683261)
1. Personalized Medicine in Gynecologic Cancer: Fact or Fiction?
Corey L; Valente A; Wade K
Obstet Gynecol Clin North Am; 2019 Mar; 46(1):155-163. PubMed ID: 30683261
[TBL] [Abstract][Full Text] [Related]
2. Personalized Medicine in Gynecologic Cancer: Fact or Fiction?
Corey L; Valente A; Wade K
Surg Oncol Clin N Am; 2020 Jan; 29(1):105-113. PubMed ID: 31757307
[TBL] [Abstract][Full Text] [Related]
3. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
4. The NCI-MATCH trial and precision medicine in gynecologic cancers.
Barroilhet L; Matulonis U
Gynecol Oncol; 2018 Mar; 148(3):585-590. PubMed ID: 29366510
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy for gynecologic cancers: Toward the era of precision medicine.
Basu P; Mukhopadhyay A; Konishi I
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():131-136. PubMed ID: 30306576
[TBL] [Abstract][Full Text] [Related]
6. Rational selection of biomarker driven therapies for gynecologic cancers: The more we know, the more we know we don't know.
Liu J; Westin SN
Gynecol Oncol; 2016 Apr; 141(1):65-71. PubMed ID: 27016231
[TBL] [Abstract][Full Text] [Related]
7. Is the NCI MATCH trial a match for gynecologic oncology?
Moore KN; Mannel RS
Gynecol Oncol; 2016 Jan; 140(1):161-6. PubMed ID: 26586415
[TBL] [Abstract][Full Text] [Related]
8. [Significance of genetic tests in the era of personalized medicine].
Molnár JM; Magyarósi S; Németh G
Magy Onkol; 2013 Mar; 57(1):16-20. PubMed ID: 23573517
[TBL] [Abstract][Full Text] [Related]
9. Genomic testing and precision medicine--What does this mean for gynecologic oncology?
Liu J; Konstantinopoulos PA; Matulonis UA
Gynecol Oncol; 2016 Jan; 140(1):3-5. PubMed ID: 26657840
[No Abstract] [Full Text] [Related]
10. Genomic profiling of gynecologic cancers and implications for clinical practice.
Prendergast EN; Elvin JA
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):18-25. PubMed ID: 27984344
[TBL] [Abstract][Full Text] [Related]
11. Biologic therapies and personalized medicine in gynecologic malignancies.
Schiavone MB; Bashir S; Herzog TJ
Obstet Gynecol Clin North Am; 2012 Jun; 39(2):131-44. PubMed ID: 22640707
[TBL] [Abstract][Full Text] [Related]
12. Moving From Mutation to Actionability.
Colombo I; Kurnit KC; Westin SN; Oza AM
Am Soc Clin Oncol Educ Book; 2018 May; 38():495-503. PubMed ID: 30231353
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers.
Somasegar S; Hoppenot C; Kuchta K; Sereika A; Khandekar J; Rodriguez G; Moore E; Hurteau J; Vogel TJ
Gynecol Oncol; 2021 Nov; 163(2):220-228. PubMed ID: 34511240
[TBL] [Abstract][Full Text] [Related]
14. Genomic insights in gynecologic cancer.
Roddy E; Chapman J
Curr Probl Cancer; 2017; 41(1):8-36. PubMed ID: 28088330
[TBL] [Abstract][Full Text] [Related]
15. The roles of pathology in targeted therapy of women with gynecologic cancers.
Murali R; Grisham RN; Soslow RA
Gynecol Oncol; 2018 Jan; 148(1):213-221. PubMed ID: 29174566
[TBL] [Abstract][Full Text] [Related]
16. [Cancer: three eras of personalized medicine].
Jordan B
Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
[TBL] [Abstract][Full Text] [Related]
17. The 61st Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO).
Yoshihara K; Sekine M; Nishino K; Enomoto T
J Gynecol Oncol; 2019 Nov; 30(6):e114. PubMed ID: 31576699
[No Abstract] [Full Text] [Related]
18. Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform.
Taghizadeh H; Mader RM; Müllauer L; Aust S; Polterauer S; Kölbl H; Seebacher V; Grimm C; Reinthaller A; Prager GW
Oncologist; 2020 Jul; 25(7):e1060-e1069. PubMed ID: 32369643
[TBL] [Abstract][Full Text] [Related]
19. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
20. Reproductive and Hormonal Considerations in Women at Increased Risk for Hereditary Gynecologic Cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review.
Chen LM; Blank SV; Burton E; Glass K; Penick E; Woodard T
Gynecol Oncol; 2019 Dec; 155(3):508-514. PubMed ID: 31606283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
